Liver Cancer Incidence in Kazakhstan: Fifteen-Year Retrospective Study

The aim is to study the trends of liver cancer (LC) incidence in the regional context in Kazakhstan. The retrospective study was done using descriptive and analytical methods of oncoepidemiology. The extensive, crude and age-specific incidence rates are determined according to the generally accepted...

Full description

Saved in:

Bibliographic Details
Published in:	Asian Pacific journal of cancer prevention : APJCP Vol. 25; no. 5; pp. 1763 - 1775
Main Authors:	Igissin, Nurbek, Orazbayev, Didar, Telmanova, Zhansaya, Kudaibergenova, Indira, Mamatov, Niyazbek, Bilyalova, Zarina, Igissinova, Gulnur, Rustemova, Kulsara, Turebayev, Dulat, Jexenova, Akzhunis, Adaibayev, Kairat, Sayakov, Umetaly, Dzhumabayeva, Fatima, Muratbekova, Svetlana, Sitnikova, Luliia, Syzdykov, Nariman, Shishkin, Ivan, Kozhakhmet, Karina
Format:	Journal Article
Language:	English
Published:	Thailand West Asia Organization for Cancer Prevention 01-05-2024
Subjects:	Adolescent Adult Aged Aged, 80 and over Child Child, Preschool Female Follow-Up Studies Humans Incidence Kazakhstan - epidemiology Liver Neoplasms - epidemiology Male Middle Aged Prognosis Registries - statistics & numerical data Retrospective Studies Young Adult Kazakhstan Liver cancer Trends Kazakhstan geographical variation Incidence
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	The aim is to study the trends of liver cancer (LC) incidence in the regional context in Kazakhstan. The retrospective study was done using descriptive and analytical methods of oncoepidemiology. The extensive, crude and age-specific incidence rates are determined according to the generally accepted methodology used in sanitary statistics. The data were used to calculate the average percentage change (APС) using the Joinpoint regression analysis to determine the trend over the study period. Between 2005 and 2019, 13,510 cases of LC were documented, comprising 59.3% males and 40.7% females. Most diagnoses were seen in age groups 55-59 years (13.3%) to 75-79 years (11.7%). LC patients' average age increased from 63.6 to 64.5 years. Incidence rates per 100,000 peaked at ages 65-69 years (35.1±1.0) and 70-74 years (43.3±1.0). LC incidence notably rose in the 70-74 years age group (APC=+0.89), contrasting with declining trends in younger age groups. Regional incidence variations revealed diverse patterns, mostly demonstrating unimodal increases, and some regions displaying bimodal growth. The age-standardized incidence rate was 5.7±0.1 per 100,000, declining from 2005 to 2012 (APC: -3.93), then rising until 2019 (APC: +1.13). Gender-specific standardized rates showed varied trends. Analyses of standardized indicators indicated declining trends in most regions but increased values in specific areas. Thematic maps classified incidence rates based on standardized indicators: low (up to 5.22), average (5.22 to 7.11), high (above 7.11 per 100,000 for the entire population). The study on liver cancer in Kazakhstan reveals marked gender and age differences. The standardized incidence rate among men was twofold greater than that among women. A distinct rise in cases was noted among individuals aged 70-74 years. Regional variations in incidence were evident. These findings emphasize the necessity for focused research to comprehend the causes behind these differences, enabling customized interventions for Kazakhstan's population.
ISSN:	1513-7368 2476-762X
DOI:	10.31557/APJCP.2024.25.5.1763